ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-3X12361
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Octreotide Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-3X12361
Report
May 2025
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical

Octreotide Market Size

In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.

Octreotide Market

Octreotide Market

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Octreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Octreotide.
The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Octreotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Octreotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Octreotide Market Report

Report Metric Details
Report Name Octreotide Market
Forecasted market size in 2031 approximately US$ 2.3 million
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Sun Pharmaceutical, Chengdu Tiantaishan pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals, Yibin Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Octreotide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Octreotide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Octreotide Market size in 2031?

Ans: The Octreotide Market size in 2031 will be approximately US$ 2.3 million.

What is the market share of major companies in Octreotide Market?

Ans: Global top five manufacturers hold a share over 90%.

Who are the main players in the Octreotide Market report?

Ans: The main players in the Octreotide Market are Novartis, Sun Pharmaceutical, Chengdu Tiantaishan pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals, Yibin Pharmaceutical

What are the Application segmentation covered in the Octreotide Market report?

Ans: The Applications covered in the Octreotide Market report are Treating Severe Diarrhea, Treating Acromegaly, Others

What are the Type segmentation covered in the Octreotide Market report?

Ans: The Types covered in the Octreotide Market report are Octreotide Injection, Octreotide Powder, Octreotide Microspheres

Recommended Reports

Peptide Drugs Market

Hormonal Disorders

Neuroendocrine Disease Markets

Market trends :

Topic Trends
Global the global octreotide market is experiencing a decline in size with a negative cagr forecasted through 2031, driven by market saturation and limited new indications.
Type Octreotide Injection - octreotide injection remains the most widely used formulation due to established clinical protocols and physician familiarity.
Octreotide Powder - octreotide powder sees limited adoption as healthcare providers prefer ready-to-use injectable formats.
Octreotide Microspheres - octreotide microspheres attract interest for potential long-acting delivery but face slow uptake due to regulatory and adoption barriers.
Application Treating Severe Diarrhea - octreotide continues to be prescribed for severe diarrhea associated with certain tumors, but demand is stable with no recent expansion.
Treating Acromegaly - octreotide remains a standard therapy for acromegaly, though market growth is constrained by limited new patient populations.
Company Novartis - novartis maintains a dominant position in the global octreotide market, leveraging its established brand and distribution network.
Sun Pharmaceutical - sun pharmaceutical continues to expand its presence in emerging markets, focusing on cost-effective octreotide formulations.
Chengdu Tiantaishan pharmaceutical - chengdu tiantaishan pharmaceutical sustains its market share through regional supply chain optimization in apac.
Sinopharm A-Think Pharmaceuticals - sinopharm a-think pharmaceuticals strengthens its distribution channels in china to support octreotide sales.
Sihuan Pharmaceutical Holdings Group - sihuan pharmaceutical holdings group targets hospital procurement programs to maintain octreotide demand in domestic markets.
Shanghai Soho-Yiming Pharmaceuticals - shanghai soho-yiming pharmaceuticals focuses on local partnerships to enhance octreotide accessibility in key apac regions.
Yibin Pharmaceutical - yibin pharmaceutical leverages regional manufacturing efficiencies to remain competitive in the octreotide segment.
Region North America - north america experiences stable demand for octreotide, with no significant recent growth drivers.
EMEA - europe remains the largest octreotide market globally, driven by established treatment protocols and high diagnosis rates.
APAC - apac sees steady octreotide sales growth in china and india, supported by local manufacturing and expanding healthcare access.
LATAM - latam maintains a minor share of the octreotide market, with growth limited by healthcare infrastructure constraints.
1 Study Coverage
1.1 Octreotide Product Introduction
1.2 Market by Type
1.2.1 Global Octreotide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Market by Application
1.3.1 Global Octreotide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Octreotide Market Size Estimates and Forecasts
2.1.1 Global Octreotide Revenue 2020-2031
2.1.2 Global Octreotide Sales 2020-2031
2.2 Octreotide Market Size by Region: 2024 Versus 2031
2.3 Octreotide Sales by Region (2020-2031)
2.3.1 Global Octreotide Sales by Region: 2020-2025
2.3.2 Global Octreotide Sales Forecast by Region (2026-2031)
2.3.3 Global Octreotide Sales Market Share by Region (2020-2031)
2.4 Octreotide Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Octreotide Revenue by Region: 2020-2025
2.4.2 Global Octreotide Revenue Forecast by Region (2026-2031)
2.4.3 Global Octreotide Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Octreotide Sales by Type (2020-2031)
3.1.1.1 Global Octreotide Sales Volume by Type (2020-2031)
3.1.1.2 Global Octreotide Sales Market Share by Type (2020-2031)
3.1.2 Global Octreotide Revenue by Type (2020-2031)
3.1.2.1 Global Octreotide Revenue by Type (2020-2031)
3.1.2.2 Global Octreotide Revenue Market Share by Type (2020-2031)
3.1.3 Octreotide Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Octreotide Sales by Application (2020-2031)
3.2.1.1 Global Octreotide Sales Volume by Application (2020-2031)
3.2.1.2 Global Octreotide Sales Market Share by Application (2020-2031)
3.2.2 Global Octreotide Revenue by Application (2020-2031)
3.2.2.1 Global Octreotide Revenue by Application (2020-2031)
3.2.2.2 Global Octreotide Revenue Market Share by Application (2020-2031)
3.2.3 Octreotide Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Octreotide Injection of Octreotide Revenue Market Share by Application
3.3.2 Octreotide Powder of Octreotide Revenue Market Share by Application
3.3.3 Octreotide Microspheres of Octreotide Revenue Market Share by Application
4 Global Octreotide by Manufacturers
4.1 Global Top Octreotide Manufacturers by Sales (2020-2025)
4.1.1 Global Octreotide Sales by Manufacturer (2020-2025)
4.1.2 Global Octreotide Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Octreotide Manufacturers by Revenue (2020-2025)
4.2.1 Global Octreotide Revenue by Manufacturer (2020-2025)
4.2.2 Global Octreotide Revenue Share by Manufacturer (2020-2025)
4.3 Global Octreotide Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Octreotide Manufacturers Covered: Ranking by Revenue
4.4.2 Global Octreotide Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Octreotide Manufacturing Base Distribution, Product Type
4.5.1 Octreotide Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Octreotide Market
4.5.3 Manufacturers Octreotide Product Type and Application
4.5.4 Octreotide Injection Market Sales of Octreotide by Manufacturer
4.5.5 Octreotide Powder Market Sales of Octreotide by Manufacturer
4.5.6 Octreotide Microspheres Market Sales of Octreotide by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Novartis
5.1.1 Novartis Company Information
5.1.2 Novartis Description, Business Overview
5.1.3 Novartis Octreotide Products Offered
5.1.4 Novartis Octreotide Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Novartis Octreotide Sales by Product in 2024
5.1.6 Novartis Octreotide Sales by Application in 2024
5.1.7 Novartis Octreotide Sales by Geographic Area in 2024
5.1.8 Novartis Recent Developments
5.2 Sun Pharmaceutical
5.2.1 Sun Pharmaceutical Company Information
5.2.2 Sun Pharmaceutical Description, Business Overview
5.2.3 Sun Pharmaceutical Octreotide Products Offered
5.2.4 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sun Pharmaceutical Octreotide Sales by Product in 2024
5.2.6 Sun Pharmaceutical Octreotide Sales by Application in 2024
5.2.7 Sun Pharmaceutical Octreotide Sales by Geographic Area in 2024
5.2.8 Sun Pharmaceutical Recent Developments
5.3 Chengdu Tiantaishan pharmaceutical
5.3.1 Chengdu Tiantaishan pharmaceutical Company Information
5.3.2 Chengdu Tiantaishan pharmaceutical Description, Business Overview
5.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Products Offered
5.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Product in 2024
5.3.6 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Application in 2024
5.3.7 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Geographic Area in 2024
5.3.8 Chengdu Tiantaishan pharmaceutical Recent Developments
5.4 Sinopharm A-Think Pharmaceuticals
5.4.1 Sinopharm A-Think Pharmaceuticals Company Information
5.4.2 Sinopharm A-Think Pharmaceuticals Description, Business Overview
5.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Products Offered
5.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Product in 2024
5.4.6 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Application in 2024
5.4.7 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Geographic Area in 2024
5.4.8 Sinopharm A-Think Pharmaceuticals Recent Developments
5.5 Sihuan Pharmaceutical Holdings Group
5.5.1 Sihuan Pharmaceutical Holdings Group Company Information
5.5.2 Sihuan Pharmaceutical Holdings Group Description, Business Overview
5.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Products Offered
5.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Product in 2024
5.5.6 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Application in 2024
5.5.7 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Geographic Area in 2024
5.5.8 Sihuan Pharmaceutical Holdings Group Recent Developments
5.6 Shanghai Soho-Yiming Pharmaceuticals
5.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
5.6.2 Shanghai Soho-Yiming Pharmaceuticals Description, Business Overview
5.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Products Offered
5.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Product in 2024
5.6.6 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Application in 2024
5.6.7 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Geographic Area in 2024
5.6.8 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
5.7 Yibin Pharmaceutical
5.7.1 Yibin Pharmaceutical Company Information
5.7.2 Yibin Pharmaceutical Description, Business Overview
5.7.3 Yibin Pharmaceutical Octreotide Products Offered
5.7.4 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Yibin Pharmaceutical Octreotide Sales by Product in 2024
5.7.6 Yibin Pharmaceutical Octreotide Sales by Application in 2024
5.7.7 Yibin Pharmaceutical Octreotide Sales by Geographic Area in 2024
5.7.8 Yibin Pharmaceutical Recent Developments
6 North America
6.1 North America Octreotide Market Size YoY Growth 2020-2031
6.2 North America Octreotide Market Facts & Figures by Country
6.2.1 North America Octreotide Sales by Country (2020-2031)
6.2.2 North America Octreotide Revenue by Country (2020-2031)
6.3 North America Octreotide Sales by Type (2020-2025)
6.4 North America Octreotide Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Octreotide Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Octreotide Market Facts & Figures by Region
7.2.1 Asia-Pacific Octreotide Sales by Region (2020-2031)
7.2.2 Asia-Pacific Octreotide Revenue by Region (2020-2031)
7.3 Asia-Pacific Octreotide Sales by Type (2020-2025)
7.4 Asia-Pacific Octreotide Sales by Application (2020-2025)
8 Europe
8.1 Europe Octreotide Market Size YoY Growth 2020-2031
8.2 Europe Octreotide Market Facts & Figures by Country
8.2.1 Europe Octreotide Sales by Country (2020-2031)
8.2.2 Europe Octreotide Revenue by Country (2020-2031)
8.3 Europe Octreotide Sales by Type (2020-2025)
8.4 Europe Octreotide Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Octreotide Market Size YoY Growth 2020-2031
9.2 Latin America Octreotide Market Facts & Figures by Country
9.2.1 Latin America Octreotide Sales by Country (2020-2031)
9.2.2 Latin America Octreotide Revenue by Country (2020-2031)
9.3 Latin America Octreotide Sales by Type (2020-2025)
9.4 Latin America Octreotide Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Octreotide Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Octreotide Market Facts & Figures by Country
10.2.1 Middle East and Africa Octreotide Sales by Country (2020-2031)
10.2.2 Middle East and Africa Octreotide Revenue by Country (2020-2031)
10.3 Middle East and Africa Octreotide Sales by Type (2020-2025)
10.4 Middle East and Africa Octreotide Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Octreotide Supply Chain Analysis
11.2 Octreotide Key Raw Materials and Upstream Suppliers
11.3 Octreotide Clients Analysis
11.4 Octreotide Sales Channel and Sales Model Analysis
11.4.1 Octreotide Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Octreotide Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Octreotide Distributors
12 Octreotide Market Dynamics
12.1 Octreotide Industry Trends
12.2 Octreotide Market Drivers
12.3 Octreotide Market Challenges
12.4 Octreotide Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
List of Tables
 Table 1. Global Octreotide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Octreotide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Octreotide Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Octreotide Sales by Region (2020-2025) & (Gram)
 Table 5. Global Octreotide Sales Forecast by Region (2026-2031) & (Gram)
 Table 6. Global Octreotide Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Octreotide Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Octreotide Sales Volume by Type (2020-2025) & (Gram)
 Table 9. Global Octreotide Sales Volume by Type (2026-2031) & (Gram)
 Table 10. Global Octreotide Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Octreotide Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Octreotide Sales Volume by Application (2020-2025) & (Gram)
 Table 13. Global Octreotide Sales Volume by Application (2026-2031) & (Gram)
 Table 14. Global Octreotide Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Octreotide Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Octreotide Sales by Manufacturer (2020-2025) & (Gram)
 Table 17. Global Octreotide Sales Share by Manufacturer (2020-2025)
 Table 18. Octreotide Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Octreotide Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Octreotide Price (2020-2025) & (USD/Gram)
 Table 21. Ranking of Global Top Octreotide Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Octreotide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Octreotide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide as of 2024)
 Table 24. Octreotide Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Octreotide Market
 Table 26. Manufacturers Octreotide Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Novartis Company Information
 Table 29. Novartis Description and Business Overview
 Table 30. Novartis Octreotide Product
 Table 31. Novartis Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
 Table 32. Novartis Sales Proportion of Octreotide by Product in 2024
 Table 33. Novartis Sales Proportion of Octreotide by Application in 2024
 Table 34. Novartis Sales Proportion of Octreotide by Geographic Area in 2024
 Table 35. Novartis Recent Developments
 Table 36. Sun Pharmaceutical Company Information
 Table 37. Sun Pharmaceutical Description and Business Overview
 Table 38. Sun Pharmaceutical Octreotide Product
 Table 39. Sun Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
 Table 40. Sun Pharmaceutical Sales Proportion of Octreotide by Product in 2024
 Table 41. Sun Pharmaceutical Sales Proportion of Octreotide by Application in 2024
 Table 42. Sun Pharmaceutical Sales Proportion of Octreotide by Geographic Area in 2024
 Table 43. Sun Pharmaceutical Recent Developments
 Table 44. Chengdu Tiantaishan pharmaceutical Company Information
 Table 45. Chengdu Tiantaishan pharmaceutical Description and Business Overview
 Table 46. Chengdu Tiantaishan pharmaceutical Octreotide Product
 Table 47. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
 Table 48. Chengdu Tiantaishan pharmaceutical Sales Proportion of Octreotide by Product in 2024
 Table 49. Chengdu Tiantaishan pharmaceutical Sales Proportion of Octreotide by Application in 2024
 Table 50. Chengdu Tiantaishan pharmaceutical Sales Proportion of Octreotide by Geographic Area in 2024
 Table 51. Chengdu Tiantaishan pharmaceutical Recent Developments
 Table 52. Sinopharm A-Think Pharmaceuticals Company Information
 Table 53. Sinopharm A-Think Pharmaceuticals Description and Business Overview
 Table 54. Sinopharm A-Think Pharmaceuticals Octreotide Product
 Table 55. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
 Table 56. Sinopharm A-Think Pharmaceuticals Sales Proportion of Octreotide by Product in 2024
 Table 57. Sinopharm A-Think Pharmaceuticals Sales Proportion of Octreotide by Application in 2024
 Table 58. Sinopharm A-Think Pharmaceuticals Sales Proportion of Octreotide by Geographic Area in 2024
 Table 59. Sinopharm A-Think Pharmaceuticals Recent Developments
 Table 60. Sihuan Pharmaceutical Holdings Group Company Information
 Table 61. Sihuan Pharmaceutical Holdings Group Description and Business Overview
 Table 62. Sihuan Pharmaceutical Holdings Group Octreotide Product
 Table 63. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
 Table 64. Sihuan Pharmaceutical Holdings Group Sales Proportion of Octreotide by Product in 2024
 Table 65. Sihuan Pharmaceutical Holdings Group Sales Proportion of Octreotide by Application in 2024
 Table 66. Sihuan Pharmaceutical Holdings Group Sales Proportion of Octreotide by Geographic Area in 2024
 Table 67. Sihuan Pharmaceutical Holdings Group Recent Developments
 Table 68. Shanghai Soho-Yiming Pharmaceuticals Company Information
 Table 69. Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
 Table 70. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product
 Table 71. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
 Table 72. Shanghai Soho-Yiming Pharmaceuticals Sales Proportion of Octreotide by Product in 2024
 Table 73. Shanghai Soho-Yiming Pharmaceuticals Sales Proportion of Octreotide by Application in 2024
 Table 74. Shanghai Soho-Yiming Pharmaceuticals Sales Proportion of Octreotide by Geographic Area in 2024
 Table 75. Shanghai Soho-Yiming Pharmaceuticals Recent Developments
 Table 76. Yibin Pharmaceutical Company Information
 Table 77. Yibin Pharmaceutical Description and Business Overview
 Table 78. Yibin Pharmaceutical Octreotide Product
 Table 79. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
 Table 80. Yibin Pharmaceutical Sales Proportion of Octreotide by Product in 2024
 Table 81. Yibin Pharmaceutical Sales Proportion of Octreotide by Application in 2024
 Table 82. Yibin Pharmaceutical Sales Proportion of Octreotide by Geographic Area in 2024
 Table 83. Yibin Pharmaceutical Recent Developments
 Table 84. North America Octreotide Sales by Country (2020-2025) & (Gram)
 Table 85. North America Octreotide Sales by Country (2026-2031) & (Gram)
 Table 86. North America Octreotide Revenue by Country (2020-2025) & (US$ Million)
 Table 87. North America Octreotide Revenue by Country (2026-2031) & (US$ Million)
 Table 88. North America Octreotide Sales by Type (2020-2025) & (Gram)
 Table 89. North America Octreotide Sales by Application (2020-2025) & (Gram)
 Table 90. Asia-Pacific Octreotide Sales by Region (2020-2025) & (Gram)
 Table 91. Asia-Pacific Octreotide Sales by Region (2026-2031) & (Gram)
 Table 92. Asia-Pacific Octreotide Revenue by Region (2020-2025) & (US$ Million)
 Table 93. Asia-Pacific Octreotide Revenue by Region (2026-2031) & (US$ Million)
 Table 94. Asia-Pacific Octreotide Sales by Type (2020-2025) & (Gram)
 Table 95. Asia-Pacific Octreotide Sales by Application (2020-2025) & (Gram)
 Table 96. Europe Octreotide Sales by Country (2020-2025) & (Gram)
 Table 97. Europe Octreotide Sales by Country (2026-2031) & (Gram)
 Table 98. Europe Octreotide Revenue by Country (2020-2025) & (US$ Million)
 Table 99. Europe Octreotide Revenue by Country (2026-2031) & (US$ Million)
 Table 100. Europe Octreotide Sales by Type (2020-2025) & (Gram)
 Table 101. Europe Octreotide Sales by Application (2020-2025) & (Gram)
 Table 102. Latin America Octreotide Sales by Country (2020-2025) & (Gram)
 Table 103. Latin America Octreotide Sales by Country (2026-2031) & (Gram)
 Table 104. Latin America Octreotide Revenue by Country (2020-2025) & (US$ Million)
 Table 105. Latin America Octreotide Revenue by Country (2026-2031) & (US$ Million)
 Table 106. Latin America Octreotide Sales by Type (2020-2025) & (Gram)
 Table 107. Latin America Octreotide Sales by Application (2020-2025) & (Gram)
 Table 108. Middle East and Africa Octreotide Sales by Country (2020-2025) & (Gram)
 Table 109. Middle East and Africa Octreotide Sales by Country (2026-2031) & (Gram)
 Table 110. Middle East and Africa Octreotide Revenue by Country (2020-2025) & (US$ Million)
 Table 111. Middle East and Africa Octreotide Revenue by Country (2026-2031) & (US$ Million)
 Table 112. Middle East and Africa Octreotide Sales by Type (2020-2025) & (Gram)
 Table 113. Middle East and Africa Octreotide Sales by Application (2020-2025) & (Gram)
 Table 114. Octreotide Key Raw Materials, Industry Status and Trend
 Table 115. Octreotide Key Raw Materials and Upstream Suppliers
 Table 116. Octreotide Clients Status and Trend
 Table 117. Octreotide Typical Clients
 Table 118. Octreotide Distributors
 Table 119. Octreotide Market Trends
 Table 120. Octreotide Market Drivers
 Table 121. Octreotide Market Challenges
 Table 122. Octreotide Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Octreotide Product Picture
 Figure 2. Global Octreotide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Octreotide Sales Market Share by Type in 2024 & 2031
 Figure 4. Octreotide Injection Product Picture
 Figure 5. Octreotide Powder Product Picture
 Figure 6. Octreotide Microspheres Product Picture
 Figure 7. Global Octreotide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Octreotide Sales Market Share by Application in 2024 & 2031
 Figure 9. Treating Severe Diarrhea
 Figure 10. Treating Acromegaly
 Figure 11. Others
 Figure 12. Octreotide Report Years Considered
 Figure 13. Global Octreotide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Octreotide Market Size 2020-2031 (US$ Million)
 Figure 15. Global Octreotide Sales 2020-2031 (Gram)
 Figure 16. Global Octreotide Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Octreotide Revenue Market Share by Region (2020-2031)
 Figure 18. Global Octreotide Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Octreotide Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Octreotide Average Selling Price (ASP) by Type (2020-2025) & (USD/Gram)
 Figure 21. Global Octreotide Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Octreotide Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Octreotide Average Selling Price (ASP) by Application (2020-2025) & (USD/Gram)
 Figure 24. Octreotide Injection of Octreotide Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Octreotide Powder of Octreotide Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Octreotide Microspheres of Octreotide Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Global Octreotide Sales Share by Manufacturer in 2024
 Figure 28. Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Octreotide Injection Market Sales Proportion by Manufacturer in 2024
 Figure 30. Octreotide Powder Market Sales Proportion by Manufacturer in 2024
 Figure 31. Octreotide Microspheres Market Sales Proportion by Manufacturer in 2024
 Figure 32. North America Octreotide Revenue 2020-2031 (US$ Million)
 Figure 33. North America Octreotide Sales Market Share by Type (2020-2025)
 Figure 34. North America Octreotide Sales Market Share by Application (2020-2025)
 Figure 35. Asia-Pacific Octreotide Revenue 2020-2031 (US$ Million)
 Figure 36. Asia-Pacific Octreotide Sales Market Share by Region (2020-2031)
 Figure 37. Asia-Pacific Octreotide Revenue Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Octreotide Sales Market Share by Type (2020-2025)
 Figure 39. Asia-Pacific Octreotide Sales Market Share by Application (2020-2025)
 Figure 40. Europe Octreotide Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Europe Octreotide Sales Market Share by Country (2020-2031)
 Figure 42. Europe Octreotide Revenue Market Share by Country (2020-2031)
 Figure 43. Europe Octreotide Sales Market Share by Type (2020-2025)
 Figure 44. Europe Octreotide Sales Market Share by Application (2020-2025)
 Figure 45. Latin America Octreotide Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Latin America Octreotide Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Octreotide Revenue Market Share by Country (2020-2025)
 Figure 48. Latin America Octreotide Sales Market Share by Type (2020-2025)
 Figure 49. Latin America Octreotide Sales Market Share by Application (2020-2025)
 Figure 50. Middle East and Africa Octreotide Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 51. Middle East and Africa Octreotide Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Octreotide Revenue Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Octreotide Sales Market Share by Type (2020-2025)
 Figure 54. Middle East and Africa Octreotide Sales Market Share by Application (2020-2025)
 Figure 55. Octreotide Supply Chain (Upstream and Downstream Market)
 Figure 56. Global Production Market Share of Octreotide Raw Materials by Region in 2024
 Figure 57. Octreotide Distribution Channels
 Figure 58. Global Octreotide Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 59. Global Octreotide Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Octreotide Drugs Market Research Report 2024
Sandostatin LAR Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Manmade Version of Somatostatin Market Research Report 2024
Growth Hormone inhibiting Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Somatostatin and Somatostatin Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Somatostatin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Somatostatin for Injection Market Research Report 2024
Global Octreotide Acetate API Market Research Report 2025
Somatostatin Analogue Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Synthetic Human Growth Hormone Market Insights Forecast to 2030
Lanreotide Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Growth Hormone Treatment and Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sandostatin LAR Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Somatostatin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Lanreotide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lanreotide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Based Cancer Therapeutics Market Research Report 2024
Acromegaly Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Growth Hormone Market Research Report 2025
Global Octreotide Acetate Microspheres for Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions